Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This study is to determine the efficacy of bevacizumab and gemcitabine in combination with
radiation therapy in the preoperative treatment of potentially-resectable subjects with
pancreatic cancer.